Maryam Lustberg is an Oncology physician affiliated with Yale Cancer Center. OpenAlex indexes 647 publications with 13,483 citations (h-index 52); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
35 Park St
New Haven, CT 065191110
Telephone
203-785-4095Provider last certified this registry record 5 Feb 2026.
Clinical trials
- Unified Network for Integrated Fluid Collection at Yale
Sponsor: Yale University
- Rash & Diarrhea Prophylaxis With Capivasertib
Sponsor: Maryam Lustberg
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202527 payments$15,041openpaymentsdata.cms.gov ↗
- Bayer Healthcare Pharmaceuticals Inc.Program year202514 payments$12,045openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20258 payments$11,417openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The effect of using a large language model to respond to patient messages
The Lancet Digital Health
2024 - Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
Nature Reviews Clinical Oncology
2023 - Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2023 - Mitigating acute chemotherapy-associated adverse events in patients with cancer
Nature Reviews Clinical Oncology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Ian Krop, MD
Yale Cancer Center
Pamela Kunz, MD
Yale Cancer Center
Anne Chiang, MD
Yale Cancer Center
Charles Matouk, MD
Yale Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”